PEOPLE - Kourion Therapeutics (Germany) makes appointment:
This article was originally published in Clinica
Executive Summary
Kourion Therapeutics (Dusseldorf, Germany), a developer and manufacturer of cord blood-derrived stem cell products, has appointed Jurgen Peter as CFO and Christian van den Bos as vice-president of development and operations. Mr Peter, who has over 14 years of business management experience, most recently served as an equity investment manager at the Deutsche Beteiligungsgesellschaft and Dr van den Bos as director of biologics at Prospect Pharma.